AC Immune SA
NASDAQ:ACIU
AC Immune SA
NASDAQ:ACIU
Price:
2.31 USD
-1.7%
Market Closed
Updated:
May 11, 2024
AC Immune SA
EPS (Diluted)
|
AC Immune SA
EPS (Diluted) Peer Comparison
Comparables:
ADCT
CRSP
BSLN
IDIA
KURN
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AC Immune SA
NASDAQ:ACIU
|
EPS (Diluted)
CHf0
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
EPS (Diluted)
-$2
|
CAGR 3-Years
3%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
EPS (Diluted)
-$1
|
CAGR 3-Years
28%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
EPS (Diluted)
CHf0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Idorsia Ltd
SIX:IDIA
|
EPS (Diluted)
-CHf4
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-108%
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
EPS (Diluted)
CHf0
|
CAGR 3-Years
7%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
See Also
What is AC Immune SA's EPS (Diluted)?
EPS (Diluted)
-0.6
CHF
-0.6
CHF
Based on the financial report for Dec 31, 2023, AC Immune SA's EPS (Diluted) amounts to -0.6 CHF.
What is AC Immune SA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
5%
5%
Over the last year, the EPS (Diluted) growth was 25%. The average annual EPS (Diluted) growth rates for AC Immune SA have been 9% over the past three years , 5% over the past five years .
You don't have any saved screeners yet
